Your search returned 3 results.

Results
	1.	[Ondansetron (GR 38032F), a competitive 5-HT3 receptor antagonist as an antiemetic in cytostatic drug-induced nausea and vomiting. An open, substance-oriented phase II/III study]. [electronic resource] by Serve, H Perker, M Ertl, A Reichold, M Fink, U Berdel, W E Producer: 19910506 In: Onkologie vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer. [electronic resource] by Hanauske, A R Korfel, A Perker, M Heinrich, B Schwab, G Graf, M Depenbrock, H Höffken, G Kreuser, E D Thiel, E Zwingers, T Berdel, W E Producer: 19970904 In: Oncology vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. [electronic resource] by Hehlmann, R Berger, U Pfirrmann, M Hochhaus, A Metzgeroth, G Maywald, O Hasford, J Reiter, A Hossfeld, D K Kolb, H-J Löffler, H Pralle, H Queisser, W Griesshammer, M Nerl, C Kuse, R Tobler, A Eimermacher, H Tichelli, A Aul, C Wilhelm, M Fischer, J T Perker, M Scheid, C Schenk, M Weiss, J Meier, C R Kremers, S Labedzki, L Schmeiser, T Lohrmann, H-P Heimpel, H Producer: 20031106 In: Leukemia vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)